Lim, Michelle H.
Thurston, Lily
Eres, Robert
Rodebaugh, Thomas L.
Alvarez-Jimenez, Mario
Penn, David L.
Kostakos, Vassilis
Gleeson, John F. M.
Article History
Received: 17 December 2020
Accepted: 16 December 2022
First Online: 2 February 2023
Declarations
:
: This trial is administered by the Swinburne University of Technology. The study has been approved by Swinburne University Human Research Ethics Committee (SUHREC: R/2019/074). The trial is conducted in accordance with the Declaration of Helsinki, Good Clinical Practice guidelines, and the Australian National Statement on Ethical Conduct in Human Research [CitationRef removed]. Major protocol amendments will be submitted to SUHREC for review and approval, and then detailed in the trial registry. Full written informed consent is obtained from participants at the time of the baseline assessment by a member of the research team. A copy of the consent form can be obtained by requesting from the corresponding author. There are no restrictions of the reporting findings of this trial. Trial results will be published in full in the peer-reviewed literature.
: Not applicable.
: The authors declare that they have no competing interests.